TheraRadar
← Back
Data updated: Jul 17, 2026

Corza Medical GmbH

Biotech
Pharmaceuticals

Corza Medical GmbH is a biotechnology company with 1 FDA-approved products.

2010
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
1 Biologics

Corza Medical GmbH's Key Drugs

Corza Medical GmbH's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

Corza Medical GmbH's Recent FDA Approvals

New NDA/BLA approvals for Corza Medical GmbH over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

Corza Medical GmbH's Therapeutic Areas

Disease areas where Corza Medical GmbH has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

Corza Medical GmbH Pipeline Snapshot

Active clinical trials for Corza Medical GmbH across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling